Literature DB >> 16133551

Understanding adherence to official guidelines on statin prescribing in primary health care--a multi-level methodological approach.

H Ohlsson1, U Lindblad, T Lithman, B Ericsson, U-G Gerdtham, A Melander, L Råstam, J Merlo.   

Abstract

OBJECTIVE: The aim was to investigate the role that municipalities and out-patient health care centres (HCCs) have in understanding adherence to official guidelines on statin prescribing. Our hypothesis was that after guideline publication, adherence to recommended statin prescription would increase and variance among HCCs and municipalities would decrease. Since multi-level regression analysis (MLRA) is a relatively new methodology in pharmacoepidemiology, we also aimed to explore the application of MLRA in our investigation.
METHODS: We obtained data from the Swedish Corporation of Pharmacies record of sales regarding all initial prescriptions of statins issued between April and December 2003. We applied multi-level analysis on 34,514 individual prescriptions (level 1) nested within 226 HCCs (level 2), which in turn were nested within 33 municipalities (level 3). Temporal trends and gender differences were investigated by means of random slope analysis. Variance was expressed using median odds ratio (MOR) and interval odds ratio.
RESULTS: HCCs appeared to be more relevant than municipalities for understanding the physicians' propensity to prescribe a recommended statin (MOR(HCC) = 1.96 and MOR(Municipality) = 1.41). Overall prevalence of adherence was very low (about 20%). After publication of the guidelines, prescription of recommended statins increased, and variance among HCCs decreased but only during the first 4 months of the observation period.
CONCLUSION: The publication of official guidelines in the county of Scania exerted a positive influence on statin prescription but, at the end of the observation period, adherence was still low and practice variation high. These facts may reflect inefficient therapeutic traditions and suggest that more intensive interventions may be necessary to promote rational statin prescription.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133551     DOI: 10.1007/s00228-005-0975-9

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  25 in total

1.  Interpreting parameters in the logistic regression model with random effects.

Authors:  K Larsen; J H Petersen; E Budtz-Jørgensen; L Endahl
Journal:  Biometrics       Date:  2000-09       Impact factor: 2.571

2.  How much variation in clinical activity is there between general practitioners? A multi-level analysis of decision-making in primary care.

Authors:  Peter Davis; Barry Gribben; Roy Lay-Yee; Alastair Scott
Journal:  J Health Serv Res Policy       Date:  2002-10

3.  Approaches to combat with confounding by indication in observational studies of intended drug effects.

Authors:  Alex D McMahon
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003 Oct-Nov       Impact factor: 2.890

4.  Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression.

Authors:  Klaus Larsen; Juan Merlo
Journal:  Am J Epidemiol       Date:  2005-01-01       Impact factor: 4.897

5.  [Evaluation of the proper use of medicines in primary care. How can this be improved?].

Authors:  B González López-Valcárcel; V Ortún Rubio; J Martín Oliva; A Cabeza Mora; A López Cabañas; J A Díaz Berenguer; F Alamo Santana
Journal:  Aten Primaria       Date:  2002-10-31       Impact factor: 1.137

6.  Medical practice variations revisited.

Authors:  H L Smits
Journal:  Health Aff (Millwood)       Date:  1986       Impact factor: 6.301

7.  What constitutes good prescribing?

Authors:  N Barber
Journal:  BMJ       Date:  1995-04-08

8.  A qualitative comparative investigation of variation in general practitioners' prescribing patterns.

Authors:  Chrys Jaye; Murray Tilyard
Journal:  Br J Gen Pract       Date:  2002-05       Impact factor: 5.386

9.  Professional uncertainty and the problem of supplier-induced demand.

Authors:  J E Wennberg; B A Barnes; M Zubkoff
Journal:  Soc Sci Med       Date:  1982       Impact factor: 4.634

10.  Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

Authors:  M Vrecer; S Turk; J Drinovec; A Mrhar
Journal:  Int J Clin Pharmacol Ther       Date:  2003-12       Impact factor: 1.366

View more
  13 in total

1.  Practice variation in a longitudinal perspective: a multilevel analysis of the prescription of simvastatin in general practices between 2003 and 2009.

Authors:  Henrik Ohlsson; Marcia Vervloet; Liset van Dijk
Journal:  Eur J Clin Pharmacol       Date:  2011-06-23       Impact factor: 2.953

2.  Understanding adherence to therapeutic guidelines: a multilevel analysis of statin prescription in the Skaraborg Primary Care Database.

Authors:  Per Hjerpe; Henrik Ohlsson; Ulf Lindblad; Kristina Bengtsson Boström; Juan Merlo
Journal:  Eur J Clin Pharmacol       Date:  2010-12-29       Impact factor: 2.953

3.  Geographical and sociodemographic differences in discontinuation of medication for Chronic Obstructive Pulmonary Disease - A Cross-Classified Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA).

Authors:  Kani Khalaf; Sten Axelsson Fisk; Ann Ekberg-Jansson; George Leckie; Raquel Perez-Vicente; Juan Merlo
Journal:  Clin Epidemiol       Date:  2020-07-20       Impact factor: 4.790

4.  Characteristics of primary health care units with focus on drug information from the pharmaceutical industry and adherence to prescribing objectives: a cross-sectional study.

Authors:  Daniel Carlzon; Lena Gustafsson; Anna L Eriksson; Karin Rignér; Anders Sundström; Susanna M Wallerstedt
Journal:  BMC Clin Pharmacol       Date:  2010-02-15

5.  Approaching NIH guideline recommended care for maternal-infant health: clinical failures to use recommended antenatal corticosteroids.

Authors:  Elizabeth A Howell; Joanne Stone; Lawrence C Kleinman; Sarla Inamdar; Stephen Matseoane; Mark R Chassin
Journal:  Matern Child Health J       Date:  2009-06-04

6.  Therapeutic traditions, patient socioeconomic characteristics and physicians' early new drug prescribing--a multilevel analysis of rosuvastatin prescription in south Sweden.

Authors:  Henrik Ohlsson; Basile Chaix; Juan Merlo
Journal:  Eur J Clin Pharmacol       Date:  2008-10-04       Impact factor: 2.953

Review 7.  Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges.

Authors:  Mohamed Hassan Elnaem; Mohamad Haniki Nik Mohamed; Hasniza Zaman Huri; Shah M Azarisman; Ramadan Mohamed Elkalmi
Journal:  J Pharm Bioallied Sci       Date:  2017 Apr-Jun

8.  Variation of preoperative chest radiography utilization in Switzerland and its influencing factors: a multilevel study with claims data.

Authors:  Wenjia Wei; Oliver Gruebner; Viktor von Wyl; Beat Brüngger; Holger Dressel; Agne Ulyte; Eva Blozik; Caroline Bähler; Matthias Schwenkglenks
Journal:  Sci Rep       Date:  2018-11-30       Impact factor: 4.379

9.  Understanding the effects of a decentralized budget on physicians' compliance with guidelines for statin prescription--a multilevel methodological approach.

Authors:  Henrik Ohlsson; Juan Merlo
Journal:  BMC Health Serv Res       Date:  2007-05-08       Impact factor: 2.655

10.  Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study.

Authors:  Christina Edward; Anders Himmelmann; Susanna M Wallerstedt
Journal:  BMC Clin Pharmacol       Date:  2007-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.